Contraceptive Market Comprehensive Study by Leading Key Players: The Female Health Company, Teva Pharmaceutical Industries Limited, Allergan plc, Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD. and other

The Contraceptive Market is expected to generate revenue of $ 43.82 billion by 2022 and is expected to average 6.4% per annum in 2016-2022. The pill is expected to dominate the market throughout the study period. North America will continue to lead in 2015, accounting for more than a third of the global contraceptive market.

The emergence of advanced contraceptive methods, emergency contraceptive methods for teenagers, and increased awareness of STD infections are key factors in the growth of the contraceptive market. Increased popularity of female condoms, on-demand condoms and other new products has increased contraceptive demands, especially in developing countries.

In addition, the adoption of modern contraceptives in developing countries is contributing to significant growth in the global contraceptive market. However, side effects such as associated risks, socio-cultural effects of contraceptives, and infertility caused by the use of contraceptives are major obstacles to market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/451?utm_source=sy

The key players in the contraceptives market are highly focused to expand their business operations in the fast-growing emerging countries and launched new products to increase their market shares.

The key players profiled in this report include
• The Female Health Company
• Teva Pharmaceutical Industries Limited
• Allergan plc
• Bayer AG
• Pfizer Inc.
• Cooper Companies INC.
• Ansell LTD.
• Mayer Laboratories
• Merck & Co. Inc.
• Church & Dwight Co. Inc.

Other players in the value chain include Reckitt Benckiser Plc, BioSante Pharmaceuticals Inc., Warner Chilcott Company, Agile Therapeutics Inc., MANKIND Pharmaceuticals, HLL Lifecare Limited, TTK HealthCare, Watson Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, V-Care Pharma Pvt. Ltd., Vardhman Life care pvt. Ltd., Cipla Limited and others.

Oral contraceptive drugs or oral contraceptive pills segment accounted for over 85% share in the overall contraceptive drugs market in 2015. Oral pills are the most common type of reversible contraception used globally. High effectiveness and convenience in comparison to contraceptive devices, particularly implants have made it a preferred mode of contraception.

Also, the large consumer base and government initiatives to cater the unmet need of contraception further boosts the market growth. Injectable contraceptives is the fastest growing segment in the global market, and is estimated to register a CAGR of 7.2% during the forecast period due to rise in awareness among individuals and growth in population.

Buy Now (Report & Data Pack Available with Discounted Price): @ https://www.alliedmarketresearch.com/checkout/870388?utm_source=sy

Condoms is expected to dominate the overall contraceptives device market throughout the analysis period, due to the increase in demand in developed as well as developing economies. Male condoms are more popular than female condoms; thereby significantly boosting the growth of the overall contraceptive market.

The increase in popularity of male condoms is attributed to their easy accessibility, ease-of-use, and wide acceptance across various regions. Furthermore, intrauterine (IUD) segment is anticipated to exhibit the highest growth, registering a CAGR of 10.1% during the forecast period, owing to their effectiveness in prevention of unwanted pregnancies for almost 1012 years after insertion in the body and transmission of STDs.

Based on age group, women ranging between 15 and 24 years, are the major contributors to generate highest revenue in the world contraceptive market. This is owing to the increased usage of contraceptives among the teenagers and early maturity among the teenage girls, raising the demand for contraceptives. However, women aged above 44, are the least contributor to the market growth due to the menopause in women at the age 44 and above.

The North American region accounted for majority of the share of the world contraceptives market in 2015. The North American contraceptive market is expected to maintain its lead throughout the forecast period due to increase in awareness among the population, rise in adoption of modern contraceptives, and increase in prevalence of sexually transmitted diseases such as HIV/AIDS.

The U.S. contraceptive market accounts for the largest share in the overall North America contraceptive market. Asia-Pacific region is expected to grow at the fastest pace during the study period, owing to high population base, and proactive governmental bodies that focus on birth control. Moreover, technological advancements and cost-effective contraceptive products in these regions offer lucrative opportunities to contraceptive manufacturers.

Key Findings of the Study:
• Oral contraceptive drugs or pills was the leading segment in the overall contraceptive market, accounting for $16,997 million in 2015, and is projected to grow at a CAGR of 5.6% during the forecast period.
• Contraceptive devices segment is expected to grow at a CAGR of 7.8%, owing to the increased demand for the prevention of unwanted pregnancies in home settings.
• Intrauterine (IUD) segment is projected to grow at a significant CAGR of 10.1% during the analysis period.
• Condom segment generated the highest revenue in 2015, accounted for $6,053 million in the world contraceptive devices market and projected to retain its dominance during the analysis period.
• Vaginal ring is estimated to grow at significant rate of 10.0% during the forecast period from 2016 to 2022.
• Contraceptive patch is poised to grow at a remarkable CAGR of 8.8% during the analysis period.
• North America is the major shareholder, accounting for about 32% share of the world contraceptives market.
• Germany accounted for around one-fourth share of the European contraceptives market in 2015.

Access Full Summery @ https://www.alliedmarketresearch.com/contraceptives-market?utm_source=sy

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.